SCHEMBL4759604

SCHEMBL4759604

CCOC(=O)[C@@H](C)NCC[C@@H](C)N(C(=O)OCc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.41
POLB P06746 1/20 0.41
TPSAB1 Q15661 2/20 0.40
TPSD1 Q9BZJ3 2/20 0.40
TPSG1 Q9NRR2 2/20 0.40
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
NCOR2 Q9Y618 1/20 0.39
L3MBTL1 Q9Y468 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
HSD17B10 Q99714 1/20 0.37
METAP2 P50579 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2707949 0.85 TPSAB1 (0.44) SYKPOLBTPSAB1TPSD1TPSG1
SCHEMBL19339724 0.85 TPSAB1 (0.44) SYKPOLBTPSAB1TPSD1TPSG1
SCHEMBL9977210 0.80 ITGA4 (0.40) HDAC3HDAC1HDAC2NCOR2SMN1; SMN2
SCHEMBL7410587 0.76 L3MBTL1 (0.43) SYKPOLBTPSAB1TPSD1TPSG1
SCHEMBL27963815 0.76 CTSK (0.50) SYKL3MBTL1MAPT
SCHEMBL9773175 0.74 HSD17B10 (0.44) POLBL3MBTL1SMN1; SMN2LMNAMAPT
SCHEMBL9773237 0.74 HSD17B10 (0.44) POLBL3MBTL1SMN1; SMN2LMNAMAPT
SCHEMBL2137272 0.74 POLB (0.49) SYKPOLBL3MBTL1MAPT
SCHEMBL2134853 0.74 POLB (0.49) SYKPOLBL3MBTL1MAPT
SCHEMBL2134843 0.74 POLB (0.49) SYKPOLBL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651623-B1 HEXAHYDRODIAZEPINONES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES MERCK & CO INC (US) 2008-12-17 EP disclosed